Share this post on:

Product Name: Navitoclax
Chemical Name: (R)-4-(4-((4′-chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide
SMILES Code: O=C(NS(=O)(C1=CC=C(N[C@H](CCN2CCOCC2)CSC3=CC=CC=C3)C(S(=O)(C(F)(F)F)=O)=C1)=O)C4=CC=C(N5CCN(CC6=C(C7=CC=C(Cl)C=C7)CCC(C)(C)C6)CC5)C=C4
CAS NO: 524684-52-4 Product: Primaquine (Diphosphate)
Synonym: ABT 263; ABT-263; ABT263
Chemical Formula: C47H55ClF3N5O6S3Molecular Weight: 974.61
Appearance: Solid powderMedchemexpress.com
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).Eukaryotic Initiation Factor eIF) inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Navitoclax (ABT-263) is an orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, BPubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/18653228

Share this post on:

Author: DNA_ Alkylatingdna